Intra Cellular Therapies Stock Price

0.08 (0.31%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Intra Cellular Therapies Inc ITCI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.08 0.31% 25.59 20:00:00
Open Price Low Price High Price Close Price Previous Close
25.51 25.3054 26.07 25.59 25.51
Bid Price Ask Price Spread News
25.00 27.50 2.50 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
6,461 535,603 $ 25.60 $ 13,713,911 747,646 8.9202 - 43.56
Last Trade Time Type Quantity Stock Price Currency
16:58:36 formt 2,062 $ 25.59 USD

Intra Cellular Therapies Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.05B 80.16M 71.52M $ 60.61k $ - -2.68 -7.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 64.24k 2.80%

more financials information »

Intra Cellular Therapies News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ITCI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week27.8127.9924.2125.39838,697-2.22-7.98%
1 Month23.810728.7722.91525.40811,0251.787.47%
3 Months17.6242.9917.2628.872,013,0307.9745.23%
6 Months23.1142.9917.2626.881,335,5912.4810.73%
1 Year10.1043.568.920226.511,608,34815.49153.37%
3 Years15.9143.566.7521.51902,7679.6860.84%
5 Years57.1859.966.7521.43790,274-31.59-55.25%

Intra Cellular Therapies Description

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.